Received: 31 July 2022
Accepted: 20 May 2023
First Online: 7 June 2023
: In compliance with the declaration of Helsinki, the present study was approved by the French National Health Authorities (registration number: MR 004—n° F20210825142518). All families received written information on the study and gave their consent to the anonymous use of patients’ data for research purposes. A signed free and informed consent was collected before administration of the SABR treatment.
: Not applicable.
: The authors declare that they have no competing interests relating to this study.